Aim-To assess the reliability of local international normalised ratios (INR) using a set of three international reference preparation (IRP) certified freeze dried plasmas. (J Clin Pathol 1998;51:356-359) 
Prothrombin time methodology has changed since the introduction of the WHO prothrombin time standardisation scheme (1983), as most laboratories have now replaced the manual technique on which this scheme was based by coagulometers. The international sensitivity index (ISI) of thromboplastins may be considerably modified by coagulometers and subsequent international normalised ratios (INR) derived from the ISI-that is, INR = prothrombin ratio ISI -may as a result be inaccurate. [1] [2] [3] [4] [5] Users of coagulometers therefore need a simple way of assessing the reliability of their INR, and guidance on the need for local ISI calibration of their prothrombin time system.
Freeze dried plasmas with certified manual prothrombin time values have been shown to be useful in correcting for local eVects of coagulometers on the ISI of thromboplastins. [5] [6] [7] A European Concerted Action on Anticoagulation (ECAA) multicentre study has shown that a set of 60 certified freeze dried plasmas gave a close approximation to the manual technique ISI, based on fresh plasmas from coumarin treated patients. 8 In this report I describe a simple INR screening procedure using a small set consisting of three freeze dried test plasmas prepared for the study, representing a range of INR values. A multicentre exercise has been performed among coagulometer users and a group of centres employing the manual prothrombin time technique using the same brand of commercial thromboplastin. The freeze dried plasmas were certified with INR values with an international reference preparation (IRP) for thromboplastin. Their certified INR values and acceptable limits of performance were provided to participants graphically with the plasmas for self assessment. Results outside defined acceptable INR limits were regarded as showing the need for correction. For deviations greater than this, sets of freeze dried normal plasmas or sets of abnormal freeze dried plasma calibrants were provided to participants for follow up studies. In the present report I describe the findings in the 55 centre collaborative study. If the INR of any of the three plasmas deviated by more than the ±10% from the certified INR the prothrombin time test on the plasma was to be repeated. If on repeat testing an unsatisfactory result was again obtained, participants were asked to check their MNPT by determining the mean value from the seven freeze dried normals supplied for the supplementary exercise. If after insertion of the new normal value any INR was still beyond the 10% limit a local ISI calibration with the set of 20 freeze dried plasma calibrants was to be performed.
Methods
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Results
Fifty five invited centres (51 in the United
Kingdom and four in the Republic of Ireland) returned results. Thirty six were coagulometer users of which two tested two instruments. Nineteen centres employed the manual prothrombin time technique.
Of the coagulometers, 23 of the 38 gave satisfactory results (<10% INR deviation) from the certified INR, whereas of the 19 manual techniques 16 were satisfactory with all three certified INR plasmas. The number of users of individual coagulometers is given in table 1, which shows the proportion with satisfactory INR with all three test plasmas. Of the 15 instruments which gave excessive deviation with at least one plasma, INR problems in 10 were resolved by local ISI calibration using the set of 20 abnormal freeze dried plasmas, while four were corrected by a check on the normal (MNPT) value using the freeze dried normal plasmas (table 2) . One coagulometer problem remained unresolved as the centre did not wish to pursue matters. Of the 19 users of the manual technique, 16 gave satisfactory results. Of the three remaining manual prothrombin time centres with high deviation with at least one plasma, five of nine of the INR screening plasmas fell outside the 10% limit. In all three centres the problem was found to be the result of an incorrect MNPT, and a local ISI calibration was not found necessary.
Examples of satisfactory and unsatisfactory INR screening results with manual prothrombin time tests and coagulometers are given in figs 1-4 . The examples given are typical ones and are by no means extreme examples of the unsatisfactory performance in the screening exercise.
Discussion
The United Kingdom NEQAS scheme recently highlighted significant diVerences which occur between laboratories in INR estimation. 9 The present multicentre study was the first experience of an INR screening procedure for local prothrombin time systems. A deviation of ±10% from the certified INR value has been arbitrarily defined as the limit of satisfactory performance following the example of the ECAA study, where it was felt that this was significant in terms of clinical response to an anticoagulant dose. 10 The use of an INR screening kit consisting of three certified freeze dried plasmas has confirmed that the problems of local INR deviation are mainly the result of an eVect on the ISI of the thromboplastin by coagulometers. Unsatisfactory results were recorded with a considerable proportion of these instruments (15 of 38 screenings). In contrast only three of 19 manual prothrombin time test procedures gave one or more results with the three test plasmas outside the 10% deviation limit. In none of these instances with the manual prothrombin time technique did a local ISI calibration prove necessary, as the fault was found to be in the MNPT used to obtain the prothrombin ratios from which INR are derived.
Of the 15 coagulometers which gave one or more unsatisfactory INR results with the screening plasmas, a check on the MNPT was Observed INR Mean certified INR with 10% deviation limits necessary in only four of the 15 instances, while a local ISI calibration using the sets of 20 freeze dried plasma calibrants was required in the others. However, not all coagulometers produced a dramatic diVerence in the INR from the manually certified values, as shown in table 1. The largest number of unsatisfactory results with the thromboplastin appeared to be with the coagulometer used in the largest number in the United Kingdom laboratories (ACL). Only three of 11 ACL instruments gave satisfactory screening results, whereas 20 of 27 of the other coagulometers gave satisfactory results. The marked eVect of the ACL coagulometer on the ISI of Manchester Reagent has been demonstrated previously in a multicentre national study 5 and similarly on the ISI of two other routine commercial thromboplastin reagents in an international collaborative study. 7 Although the results of the present study are based on one commercial thromboplastin reagent, it appears a reasonable assumption that they would not have been dramatically altered if a diVerent choice of a routine reagent had been made. Where routine reagents may not be well calibrated by manufacturers or alternatively diVer greatly in ISI from the relevant IRP, it can be reasonably assumed that the possibility of INR deviation may be greater and that the benefit of the INR screening procedure will therefore be even more marked.
The results prove the value of the screening kit with freeze dried plasmas certified with INR in terms of a thromboplastin IRP. They show the need for local INR correction in a considerable proportion (15 of 38) of coagulometer users. The simple screening procedure described also supported the need for reassessment of the local normal value for ISI correction with a smaller proportion of coagulometer users compared with the manual technique, where the small number of unsatisfactory results were all a result of errors in the normal.
It is not recommended, however, that the three freeze dried plasmas should be used to provide a local ISI value, as it has been shown that a minimum of 20 plasmas of this type is required for a reliable ISI result. 10 Thanks are due to the directors and technical staV of the participant centres in the United Kingdom and the Republic of Ireland for their cooperation in assessing the value of the freeze dried plasma screening procedure, and to Manchester Thrombosis Research Foundation and the Biomed 1 Programme of the European Commission (grant number PL931349) for financial support.
